Literature DB >> 27856178

UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease.

Hila Braunstein1, Gali Maor1, Gaya Chicco2, Mirella Filocamo3, Ari Zimran2, Mia Horowitz4.   

Abstract

Chronic presence of mutant, misfolded proteins in the endoplasmic reticulum (ER) initiates ER stress and induces the Unfolded Protein Response (UPR). In Gaucher disease (GD), resulting from mutations in the GBA1 gene, encoding lysosomal acid β-glucocerebrosidase (GCase), a certain fraction of the mutant variants is retained in the ER and activates the UPR. We have previously shown UPR activation in GD derived fibroblasts, in fibroblasts that derived from carriers of GD mutations and in Drosophila models of carriers of GD mutations. In the present work we extended our studies to include a large collection of fibroblasts, EBV-transformed B-cells and white blood cells (WBCs) that derived from GD patients. The results showed UPR activation in all tested cells. They also indicated that transcription of the GBA1 gene is upregulated through activation of the UPR-induced CHOP transcription factor. Transcription of the MAN2B gene, encoding alpha-mannosidase and of the ACP gene, encoding acid phosphatase was also elevated presumably through CHOP activation. Our results highlight the existence of chronic stress in GD derived cells due to the presence of ER-retained mutant GCase, which leads to upregulation of GBA1 expression.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CHOP; Gaucher disease; UPR; glucocerebrosidase

Mesh:

Substances:

Year:  2016        PMID: 27856178     DOI: 10.1016/j.bcmd.2016.10.025

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

Review 1.  GBA Variants and Parkinson Disease: Mechanisms and Treatments.

Authors:  Laura Smith; Anthony H V Schapira
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

Review 2.  Gaucher disease - more than just a rare lipid storage disease.

Authors:  Jaehyeok Roh; Subbaya Subramanian; Neal J Weinreb; Reena V Kartha
Journal:  J Mol Med (Berl)       Date:  2022-01-23       Impact factor: 4.599

3.  CRISPR/Cas9 Editing for Gaucher Disease Modelling.

Authors:  Eleonora Pavan; Maximiliano Ormazabal; Paolo Peruzzo; Emilio Vaena; Paula Rozenfeld; Andrea Dardis
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

4.  Misfolding of Lysosomal α-Galactosidase a in a Fly Model and Its Alleviation by the Pharmacological Chaperone Migalastat.

Authors:  Hila Braunstein; Maria Papazian; Gali Maor; Jan Lukas; Arndt Rolfs; Mia Horowitz
Journal:  Int J Mol Sci       Date:  2020-10-07       Impact factor: 5.923

5.  NADPH Oxidase 5 Induces Changes in the Unfolded Protein Response in Human Aortic Endothelial Cells and in Endothelial-Specific Knock-in Mice.

Authors:  Adriana Cortés; Álvaro Pejenaute; Javier Marqués; Íñigo Izal; Silvia Cenoz; Eduardo Ansorena; Juan José Martínez-Irujo; Carlos de Miguel; Guillermo Zalba
Journal:  Antioxidants (Basel)       Date:  2021-01-29

6.  Mechanistic Insight into the Mode of Action of Acid β-Glucosidase Enhancer Ambroxol.

Authors:  Supansa Pantoom; Larissa Hules; Christopher Schöll; Andranik Petrosyan; Maria Monticelli; Jola Pospech; Maria Vittoria Cubellis; Andreas Hermann; Jan Lukas
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 7.  Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity.

Authors:  Daniel Ysselstein; Tiffany J Young; Maria Nguyen; Shalini Padmanabhan; Warren D Hirst; Nicolas Dzamko; Dimitri Krainc
Journal:  Mov Disord       Date:  2021-10-06       Impact factor: 9.698

Review 8.  Autophagic and endo-lysosomal dysfunction in neurodegenerative disease.

Authors:  Bilal R Malik; Daniel C Maddison; Gaynor A Smith; Owen M Peters
Journal:  Mol Brain       Date:  2019-11-29       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.